Cognitive effects of testosterone and finasteride administration in older hypogonadal men
- PMID: 25143719
- PMCID: PMC4136953
- DOI: 10.2147/CIA.S61760
Cognitive effects of testosterone and finasteride administration in older hypogonadal men
Abstract
Serum concentrations of neuroactive androgens decline in older men and, in some studies, low testosterone is associated with decreased cognitive function and incidence of depression. Existing studies evaluating the effect of testosterone administration on cognition in older men have been largely inconclusive, with some studies reporting minor to moderate cognitive benefit, while others indicate no cognitive effect. Our objective was to assess the cognitive effects of treating older hypogonadal men for 1 year with a supraphysiological dose of testosterone, either alone or in combination with finasteride (a type II 5α-reductase inhibitor), in order to determine whether testosterone produces cognitive benefit and whether suppressed dihydrotestosterone influences cognition. Sixty men aged ≥ 60 years with a serum testosterone concentration of ≤ 300 ng/dL or bioavailable testosterone ≤ 70 ng/dL and no evidence of cognitive impairment received testosterone-enanthate (125 mg/week) versus vehicle, paired with finasteride (5 mg/day) versus placebo using a 2×2 factorial design. Testosterone caused a small decrease in depressive symptoms as assessed by the Geriatric Depression Scale and a moderate increase in visuospatial memory as assessed by performance on a recall trial of the Rey-Osterrieth Complex Figure Test. Finasteride caused a small increase in performance on the Benton Judgment of Line Orientation test. In total, major improvements in cognition were not observed either with testosterone or finasteride. Further studies are warranted to determine if testosterone replacement may improve cognition in other domains.
Keywords: 5 alpha reductase; cognition; depression; testosterone enanthate.
Similar articles
-
Musculoskeletal and prostate effects of combined testosterone and finasteride administration in older hypogonadal men: a randomized, controlled trial.Am J Physiol Endocrinol Metab. 2014 Feb 15;306(4):E433-42. doi: 10.1152/ajpendo.00592.2013. Epub 2013 Dec 10. Am J Physiol Endocrinol Metab. 2014. PMID: 24326421 Free PMC article. Clinical Trial.
-
Exogenous testosterone alone or with finasteride does not improve measurements of cognition in healthy older men with low serum testosterone.J Androl. 2007 Nov-Dec;28(6):875-82. doi: 10.2164/jandrol.107.002931. Epub 2007 Jul 3. J Androl. 2007. PMID: 17609296 Clinical Trial.
-
Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T.J Clin Endocrinol Metab. 2005 Mar;90(3):1502-10. doi: 10.1210/jc.2004-1933. Epub 2004 Nov 30. J Clin Endocrinol Metab. 2005. PMID: 15572415 Clinical Trial.
-
Testosterone and cognitive function: current clinical evidence of a relationship.Eur J Endocrinol. 2006 Dec;155(6):773-81. doi: 10.1530/eje.1.02306. Eur J Endocrinol. 2006. PMID: 17132744 Review.
-
Role of testosterone in cognition and mobility of aging men.Andrology. 2020 Nov;8(6):1567-1579. doi: 10.1111/andr.12872. Epub 2020 Aug 31. Andrology. 2020. PMID: 32700462 Review.
Cited by
-
Testosterone Replacement Therapy in the Treatment of Depression.Health Psychol Res. 2022 Nov 26;10(4):38956. doi: 10.52965/001c.38956. eCollection 2022. Health Psychol Res. 2022. PMID: 36452903 Free PMC article.
-
[Testosterone and Alzheimer's disease].Probl Endokrinol (Mosk). 2022 Jun 24;68(5):97-107. doi: 10.14341/probl13136. Probl Endokrinol (Mosk). 2022. PMID: 36337024 Free PMC article. Russian.
-
Effect of High Testosterone Levels on Endothelial Function in Aorta and Erectile Function in Rats.Sex Med. 2022 Oct;10(5):100550. doi: 10.1016/j.esxm.2022.100550. Epub 2022 Aug 5. Sex Med. 2022. PMID: 35939869 Free PMC article.
-
Impact of Testosterone on Alzheimer's Disease.World J Mens Health. 2022 Apr;40(2):243-256. doi: 10.5534/wjmh.210175. Epub 2022 Jan 2. World J Mens Health. 2022. PMID: 35021306 Free PMC article. Review.
-
An Updated Review: Androgens and Cognitive Impairment in Older Men.Front Endocrinol (Lausanne). 2020 Nov 13;11:586909. doi: 10.3389/fendo.2020.586909. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 33281745 Free PMC article. Review.
References
-
- Moffat SD, Zonderman AB, Metter EJ, Blackman MR, Harman SM, Resnick SM. Longitudinal assessment of serum free testosterone concentration predicts memory performance and cognitive status in elderly men. J Clin Endocrinol Metab. 2002;87(11):5001–5007. - PubMed
-
- Shores MM, Moceri VM, Sloan KL, Matsumoto AM, Kivlahan DR. Low testosterone levels predict incident depressive illness in older men: effects of age and medical morbidity. J Clin Psychiatry. 2005;66(1):7–14. - PubMed
-
- Hawley WR, Grissom EM, Martin RC, Halmos MB, Bart CL, Dohanich GP. Testosterone modulates spatial recognition memory in male rats. Horm Behav. 2013;63(4):559–565. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources